Oleocanthal enhances amyloid-β clearance from the brains of TgSwDI mice and in vitro across a human blood-brain barrier model

ACS Chemical Neuroscience
Hisham QosaAmal Kaddoumi

Abstract

Numerous clinical and preclinical studies have suggested several health promoting effects for the dietary consumption of extra-virgin olive oil (EVOO) that could protect and decrease the risk of developing Alzheimer's disease (AD). Moreover, recent studies have linked this protective effect to oleocanthal, a phenolic secoiridoid component of EVOO. This protective effect of oleocanthal against AD has been related to its ability to prevent amyloid-β (Aβ) and tau aggregation in vitro, and enhance Aβ clearance from the brains of wild type mice in vivo; however, its effect in a mouse model of AD is not known. In the current study, we investigated the effect of oleocanthal on pathological hallmarks of AD in TgSwDI, an animal model of AD. Mice treatment for 4 weeks with oleocanthal significantly decreased amyloid load in the hippocampal parenchyma and microvessels. This reduction was associated with enhanced cerebral clearance of Aβ across the blood-brain barrier (BBB). Further mechanistic studies demonstrated oleocanthal to increase the expression of important amyloid clearance proteins at the BBB including P-glycoprotein and LRP1, and to activate the ApoE-dependent amyloid clearance pathway in the mice brains. The anti-inflammatory ...Continue Reading

References

Mar 29, 2001·Physiological Reviews·D J Selkoe
Jan 28, 2003·European Journal of Clinical Nutrition·L Filik, O Ozyilkan
Jan 29, 2003·The Journal of Nutritional Biochemistry·Kellie L. Tuck, Peter J. Hayball
Apr 17, 2003·Proceedings of the National Academy of Sciences of the United States of America·John F ReillyFloyd E Bloom
May 28, 2004·European Journal of Clinical Nutrition·M N VissersM B Katan
Aug 7, 2004·Clinical Nutrition : Official Journal of the European Society of Parenteral and Enteral Nutrition·C M AguileraA Gil
Sep 2, 2005·Nature·Gary K BeauchampPaul A S Breslin
Oct 22, 2005·The Journal of Clinical Investigation·John R CirritoDavid M Holtzman
Mar 31, 2006·The British Journal of Nutrition·Simonetta SalviniDomenico Palli
Apr 15, 2006·Brain Pathology·Sandy X Zhang-NunesSteven M Greenberg
Apr 20, 2006·Annals of Neurology·Nikolaos ScarmeasJose A Luchsinger
May 5, 2006·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Saurav BrahmachariKalipada Pahan
Sep 26, 2006·Drug Discovery Today·Yan-Jiang WangXin-Fu Zhou
Oct 13, 2006·Archives of Neurology·Nikolaos ScarmeasJose A Luchsinger
Jan 25, 2007·Nature Reviews. Molecular Cell Biology·Christian Haass, Dennis J Selkoe
Jun 1, 2005·Nutrition Research Reviews·Elisa TripoliMaurizio La Guardia
Feb 3, 2009·Acta Neuropathologica·Khalid IqbalInge Grundke-Iqbal
Feb 11, 2009·Archives of Neurology·Nikolaos ScarmeasJose A Luchsinger
Mar 26, 2009·Acta Neuropathologica·Robert D Bell, Berislav V Zlokovic
Jan 15, 2010·The British Journal of Nutrition·Vanessa PitozziLisa Giovannelli
Apr 14, 2010·International Journal of Molecular Sciences·Sara CiceraleRussell Keast
Jul 29, 2010·The Journal of Biological Chemistry·Alejandra D AlonsoKhalid Iqbal
Aug 3, 2010·Trends in Endocrinology and Metabolism : TEM·Philippe LefebvreBart Staels
Sep 18, 2010·Journal of Alzheimer's Disease : JAD·Yian GuNikolaos Scarmeas
Aug 16, 2011·Journal of Visualized Experiments : JoVE·Philip T T LyWeihong Song
Oct 1, 2011·Journal of Alzheimer's Disease : JAD·Susan A FarrMario Barbagallo
Oct 4, 2012·Translational Psychiatry·S GardenerUNKNOWN AIBL Research Group
Jan 4, 2013·The Journal of Biological Chemistry·Javier Pacheco-Quinto, Elizabeth A Eckman
Jul 16, 2013·Alzheimer's Research & Therapy·Kristin R WildsmithGary E Landreth

❮ Previous
Next ❯

Citations

Feb 4, 2016·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Lucía Fernández del RíoJosé M Villalba
Apr 12, 2016·Frontiers in Pharmacology·Lieven D DeclercqGuy Bormans
Jun 4, 2016·European Journal of Medicinal Chemistry·Mohamed M MohyeldinKhalid A El Sayed
Jul 23, 2016·Clinical Pharmacology and Therapeutics·H QosaA Kaddoumi
Oct 21, 2016·Expert Review of Neurotherapeutics·Fiorella Casamenti, Massimo Stefani
Dec 22, 2016·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Lisa Parkinson, Sara Cicerale
Mar 10, 2016·International Journal of Molecular Sciences·Yazan S BatarsehAmal Kaddoumi
May 8, 2018·Nutrients·Kok-Lun Pang, Kok-Yong Chin
Jan 11, 2018·Oxidative Medicine and Cellular Longevity·Giulia SitaFabiana Morroni
Mar 22, 2019·Natural Product Research·Vita Di Stefano, Maria Grazia Melilli
Jun 12, 2019·International Journal of Molecular Sciences·Syed Haris Omar
May 30, 2019·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Ana Karković MarkovićCvijeta Jakobušić Brala
Jul 5, 2019·British Journal of Pharmacology·Francesco VisioliJoao Tomé-Carneiro
Sep 19, 2019·International Journal of Food Sciences and Nutrition·Filipa GriloVita Di Stefano
Feb 7, 2020·International Journal of Molecular Sciences·Romain VerselePietra Candela
Apr 19, 2016·Oncotarget·Mohamed M MohyeldinKhalid A El Sayed
Jul 22, 2018·Cellular and Molecular Life Sciences : CMLS·Zohra DhouafliInes Moreno-Gonzalez
Aug 12, 2018·International Journal of Molecular Sciences·Laura GiustiSilvana Hrelia
Feb 19, 2019·Journal of Alzheimer's Disease : JAD·Alberto Serrano-Pozo, John H Growdon
May 15, 2019·International Journal of Molecular Sciences·Stephanie AndradeMaria do Carmo Pereira
Aug 20, 2019·Critical Reviews in Food Science and Nutrition·Julián Lozano-CastellónRosa M Lamuela-Raventós
Jun 13, 2018·Current Nutrition Reports·Hannah Gardener, Michelle R Caunca
Sep 27, 2018·International Journal of Molecular Sciences·Antonio Segura-Carretero, Jose Antonio Curiel
May 26, 2020·Phytotherapy Research : PTR·Mohammed El HaouariJuan A Rosado
Jul 16, 2019·Journal of Alzheimer's Disease : JAD·Rebecca Parodi-RullánSilvia Fossati
Feb 9, 2020·Pharmaceutics·Anallely López-YerenaElvira Escribano-Ferrer
Sep 16, 2019·Revue neurologique·G C RománE Toledo
Jan 31, 2021·International Journal of Molecular Sciences·Ihab M AbdallahAmal Kaddoumi
Jan 31, 2021·International Journal of Molecular Sciences·Maria Rita EmmaAntonella Cusimano
Feb 20, 2021·Journal of the Neurological Sciences·Sarah LyeFrancesca Fernandez
Apr 4, 2021·Antioxidants·Julián Lozano-CastellónAnna Vallverdú-Queralt

❮ Previous
Next ❯

Methods Mentioned

BETA
ELISA

Software Mentioned

Signalway
ImageJ

Related Concepts

Related Feeds

Blood Brain Barrier

The blood brain barrier is a border that separates blood from cerebrospinal fluid. Discover the latest search on this highly selective semipermeable membrane here.

Blood Brain Barrier Regulation in Health & Disease

The blood brain barrier is essential in regulating the movement of molecules and substances in and out of the brain. Disruption to the blood brain barrier and changes in permeability allow pathogens and inflammatory molecules to cross the barrier and may play a part in the pathogenesis of neurodegenerative disorders. Here is the latest research in this field.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

Alzheimer's Disease: Tau & TDP-43

Alzheimer's disease is a neurodegenerative disease. This feed focuses on the underlying role of tau proteins and TAR DNA-binding protein 43, as well as other genetic factors, in Alzheimer's disease.

Astrocytes

Astrocytes are glial cells that support the blood-brain barrier, facilitate neurotransmission, provide nutrients to neurons, and help repair damaged nervous tissues. Here is the latest research.

Alzheimer's Disease: APOE

Apolipoprotein E (APOE) polymorphic alleles are major genetic risk factors for Alzheimer's disease. Discover the latest research on APOE and other genetic determinants of Alzheimer's disease here.

Astrocytes in Repair & Regeneration

Astrocytes are glial cells found within the CNS and are able to regenerate new neurons. They become activated during CNS injury and disease. The activation leads to the transcription of new genes and the repair and regeneration of neurons. Discover the latest research on astrocytes in repair and regeneration here.

Astrocytes & Amyloid

Astrocytes are thought to play a role in amyloid production and have been implicated in neurodegenerative diseases such as Alzheimer’s disease. Here is the latest research on the relationship between astrocytes and amyloid.

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.

Alzheimer's Disease: Animal Models

Alzheimer's disease is a neurodegenerative disease which can be studied using various experimental systems. This feed focuses on animal models used for Alzheimer's disease research.

Blood Brain Barrier Chips

The blood brain barrier (BBB) is comprised of endothelial cells that regulate the influx and outflux of plasma concentrations. Lab-on-a-chip devices allow scientists to model diseases and mechanisms such as the passage of therapeutic antibodies across the BBB. Discover the latest research on BBB chips here.